Boehringer Ingelheim named one of the most innovative companies worldwide
Ingelheim, 16 November 2015 - Boehringer Ingelheim has been named one of the most innovative companies worldwide in 2015. For the first time,...
Post Marketing Commitments of Pfizer
As part of the United States regulatory approval process for new medicines, new uses of existing medicines and the continuous monitoring of safety, companies...
Keytruda Approved for Leading Form of Lung Cancer
Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat advanced cases of the most common type of lung malignancy,...
Bayer aligns organization with Life Science businesses
Operational management in three divisions: Pharmaceuticals, Consumer Health and Crop Science / Dieter Weinand, Erica Mann and Liam Condon appointed to the Bayer...
Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn
Ireland-based Perrigo has completed the acquisition of Belgium's over-the-counter (OTC) drugmaker Omega Pharma for around €3.8bn ($4.5bn). As part of the deal, Perrigo...
Ireland’s Horizon Pharma to buy Hyperion for $1.1bn
Irish biopharmaceutical firm Horizon Pharma has signed an agreement to acquire US-based Hyperion Therapeutics for around $1.1bn. As part of the deal, Horizon...
CHMP recommends new single-pill combination therapy to treat type 2 diabetes
30 March 2015 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer Ingelheim (BI) and Eli...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...